tiprankstipranks
Trending News
More News >
Clarity Pharmaceuticals Ltd. (AU:CU6)
ASX:CU6
Australian Market

Clarity Pharmaceuticals Ltd. (CU6) Ratios

Compare
285 Followers

Clarity Pharmaceuticals Ltd. Ratios

AU:CU6's free cash flow for Q2 2026 was AU$0.00. For the 2026 fiscal year, AU:CU6's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
11.43 9.69 19.05 10.17 13.26
Quick Ratio
11.43 9.69 19.05 10.17 13.26
Cash Ratio
10.14 4.59 5.92 4.14 7.37
Solvency Ratio
-4.20 -5.86 -5.06 -3.17 -3.13
Operating Cash Flow Ratio
-3.24 -5.28 -5.35 -3.65 -1.77
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 232.14MAU$ 89.66MAU$ 145.73MAU$ 68.96MAU$ 91.96M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.10 1.12 1.06 1.11 1.08
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
2.23 0.69 1.07 0.91 1.84
Profitability Margins
Gross Profit Margin
96.85%100.00%100.00%98.97%99.28%
EBIT Margin
-2131.42%-730.16%-389.35%-349.98%-467.51%
EBITDA Margin
-2126.21%-728.21%-388.02%-348.95%-466.79%
Operating Profit Margin
-2131.42%-730.16%-389.35%-369.00%-263.94%
Pretax Profit Margin
-2122.34%-675.05%-365.26%-249.98%-367.51%
Net Profit Margin
-2015.88%-679.45%-367.83%-251.03%-367.78%
Continuous Operations Profit Margin
-2015.88%-679.45%-367.83%-251.03%-367.78%
Net Income Per EBT
94.98%100.65%100.70%100.42%100.07%
EBT Per EBIT
99.57%92.45%93.81%67.74%139.24%
Return on Assets (ROA)
-37.65%-63.55%-27.37%-31.99%-23.80%
Return on Equity (ROE)
-59.59%-71.26%-28.93%-35.57%-25.75%
Return on Capital Employed (ROCE)
-43.61%-76.10%-30.57%-52.14%-18.47%
Return on Invested Capital (ROIC)
-41.42%-76.10%-30.57%-52.14%-18.47%
Return on Tangible Assets
-37.65%-63.55%-27.37%-31.99%-23.80%
Earnings Yield
-7.74%-8.06%-3.01%-13.54%-18.80%
Efficiency Ratios
Receivables Turnover
0.28 0.94 0.91 0.98 0.97
Payables Turnover
0.02 0.00 0.07 0.04 0.02
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
7.26 17.13 20.74 47.54 24.83
Asset Turnover
0.02 0.09 0.07 0.13 0.06
Working Capital Turnover Ratio
0.03 0.08 0.11 0.12 0.12
Cash Conversion Cycle
-17.96K 389.47 -4.57K -9.96K -22.11K
Days of Sales Outstanding
1.28K 389.47 400.78 372.51 376.23
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
19.25K 0.00 4.97K 10.34K 22.49K
Operating Cycle
1.28K 389.47 400.78 372.51 376.23
Cash Flow Ratios
Operating Cash Flow Per Share
-0.20 -0.17 -0.16 -0.11 -0.05
Free Cash Flow Per Share
-0.20 -0.17 -0.16 -0.11 -0.05
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.01 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
-214.59 -299.71 -85.79 -590.61 -62.46
Capital Expenditure Coverage Ratio
-214.59 -299.71 -85.79 -590.61 -62.46
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
-15.13 -5.79 -3.76 -2.81 -2.06
Free Cash Flow Yield
-5.70%-6.89%-3.12%-15.16%-10.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-12.93 -12.41 -33.17 -7.39 -5.32
Price-to-Sales (P/S) Ratio
266.65 84.33 122.02 18.54 19.56
Price-to-Book (P/B) Ratio
5.34 8.84 9.60 2.63 1.37
Price-to-Free Cash Flow (P/FCF) Ratio
-17.54 -14.52 -32.10 -6.60 -9.34
Price-to-Operating Cash Flow Ratio
-17.22 -14.57 -32.47 -6.61 -9.49
Price-to-Earnings Growth (PEG) Ratio
0.32 -0.37 -0.56 6.42 -0.04
Price-to-Fair Value
5.34 8.84 9.60 2.63 1.37
Enterprise Value Multiple
-10.31 -10.89 -30.37 -4.40 -2.35
Enterprise Value
1.05B 750.32M 1.36B 150.51M 70.99M
EV to EBITDA
-10.31 -10.89 -30.37 -4.40 -2.35
EV to Sales
219.27 79.29 117.86 15.36 10.99
EV to Free Cash Flow
-14.42 -13.65 -31.00 -5.46 -5.25
EV to Operating Cash Flow
-14.49 -13.70 -31.37 -5.47 -5.33
Tangible Book Value Per Share
0.64 0.28 0.54 0.27 0.37
Shareholders’ Equity Per Share
0.64 0.28 0.54 0.27 0.37
Tax and Other Ratios
Effective Tax Rate
0.05 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
0.01 0.03 0.04 0.04 0.03
Net Income Per Share
-0.26 -0.20 -0.15 -0.09 -0.10
Tax Burden
0.95 1.01 1.01 1.00 1.00
Interest Burden
1.00 0.92 0.94 0.71 0.79
Research & Development to Revenue
18.60 7.07 3.98 3.21 2.93
SG&A to Revenue
1.17 1.22 0.90 0.21 1.40
Stock-Based Compensation to Revenue
1.28 0.00 0.00 0.13 0.31
Income Quality
0.75 0.00 1.02 1.12 0.56
Currency in AUD